Meloximed Forte (Meloxicam)

Meloxicam works by selectively inhibiting the cyclooxygenase‑2 (COX‑2) enzyme, which reduces the production of prostaglandins—chemical mediators that cause inflammation, pain and fever. By lowering prostaglandin levels, meloxicam diminishes the inflammatory response while sparing COX‑1 activity that protects the stomach lining.

The appropriate dose of Meloximed Forte is determined by the prescribing healthcare professional based on the patient’s condition, severity of symptoms, age, renal and hepatic function, and other individual factors. Only a qualified prescriber should set the dosage and duration of therapy.

Safety of meloxicam in pregnancy or while breastfeeding has not been definitively established. It is generally advised to avoid NSAIDs during the third trimester and to discuss potential risks with a healthcare provider before using meloxicam if you are pregnant, planning pregnancy, or nursing.

To place an order, submit an enquiry on the Meloximed Forte product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Meloxicam is a COX‑2‑selective NSAID, offering anti‑inflammatory and analgesic effects similar to other NSAIDs but with a lower incidence of gastrointestinal irritation compared with non‑selective agents like ibuprofen or naproxen. However, it still carries cardiovascular and renal risks that must be weighed against benefits.

Meloximed Forte should be stored at ambient temperature, preferably below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and do not use it after the expiry date printed on the label.

Meloximed Forte is taken orally, usually with a full glass of water. It may be taken with or without food, but taking it with food can help reduce possible stomach upset. Follow the prescriber’s instructions regarding timing and any dose adjustments.

Serious risks include gastrointestinal bleeding or ulcer perforation, cardiovascular events such as heart attack or stroke, acute renal failure, severe skin reactions (e.g., Stevens‑Johnson syndrome), and significant liver enzyme elevations. Patients should be monitored closely for signs of these complications.

Meloxicam should be avoided in individuals with known hypersensitivity to meloxicam or other NSAIDs, active peptic ulcer disease, severe heart failure, uncontrolled hypertension, significant renal or hepatic impairment, and in patients who are in the third trimester of pregnancy. A healthcare professional should evaluate suitability before prescribing.